Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-01 Sale |
2023-06-02 5:01 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
6,500 | $4.4537 | $28,949 | 783,066 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-02 5:01 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
6,800 | $4.424 | $30,083 | 789,566 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-04 5:03 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
6,700 | $3.691 | $24,730 | 796,366 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 5:04 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
7,000 | $3.4243 | $23,970 | 806,681 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 5:08 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
7,700 | $3.7923 | $29,201 | 928,681 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-04 7:30 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
6,970 | $3.1759 | $22,136 | 751,913 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-05 4:35 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
9,400 | $3.9089 | $36,744 | 761,151 (Direct) |
View |
| 2022-10-03 Sale(A) |
2022-11-23 5:01 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
9,500 | $3.9061 | $37,108 | 1,570,002 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 4:49 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
9,700 | $4.0263 | $39,055 | 765,059 (Direct) |
View |
| 2022-09-30 Sale |
2022-10-04 4:59 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
14,992 | $3.9415 | $59,091 | 774,759 (Direct) |
View |
| 2022-09-01 Sale |
2022-09-02 5:00 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
10,423 | $4.4121 | $45,987 | 789,751 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-03 6:00 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
10,423 | $4.4522 | $46,405 | 800,174 (Direct) |
View |
| 2022-07-18 Sale |
2022-07-20 6:00 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
20,000 | $4.8656 | $97,312 | 810,597 (Direct) |
View |
| 2022-07-01 Sale |
2022-07-06 6:16 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
9,100 | $5.0326 | $45,797 | 830,597 (Direct) |
View |
| 2022-06-17 Sale |
2022-06-21 7:23 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
9,200 | $4.6778 | $43,036 | 739,697 (Direct) |
View |
| 2022-05-17 Sale |
2022-05-19 6:01 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
85,000 | $5.1733 | $439,734 | 748,897 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-31 Tax Withholding |
2023-04-04 5:03 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
3,615 | $3.9 | 796,366 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:08 pm |
N/A 2033-02-01 |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
192,200 | $0 | 928,681 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2023-01-13 5:40 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
7,732 | $4.25 | 782,019 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 7:30 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
2,268 | $3.1 | 751,913 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 6:16 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
100,000 | $0 | 830,597 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 6:30 pm |
N/A 2032-02-01 |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE Chief Medical Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-05-27 Option Award |
2021-06-01 8:48 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE Chief Medical Officer |
833,897 | $0 | 833,897 (Direct) |
View |